Genome-wide CRISPR Screening Reveals a PKA-Driven Resistance Mechanism to Metformin for Oral Cancer Prevention That Can Be Exploited by Combination with NSAIDs

Our findings reveal that using metformin for head and neck cancer chemoprevention leads to compensatory activation of a PKA-driven resistance mechanism that can be blocked by cotreatment with NSAIDs. These findings provide a rationale for combining metformin with NSAIDs as a precision head and neck cancer chemoprevention strategy.

Authors

Institutions

Publication Details

Journal
Cancer Prevention Research
Published
2025-12-19
DOI
https://doi.org/10.1158/1940-6207.capr-25-0264
Primary Topic
Metabolism, Diabetes, and Cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Genome-wide CRISPR Screening Reveals a PKA-Driven Resistance Mechanism to Metformin for Oral Cancer Prevention That Can Be Exploited by Combination with NSAIDs

Ezra E.W. Cohen, Sendi Rafael Adame-Garcia, Thomas S. Hoang, Kuniaki Sato et al.
Cancer Prevention Research
Metabolism, Diabetes, and Cancer
article

Genome-wide CRISPR Screening Reveals a PKA-Driven Resistance Mechanism to Metformin for Oral Cancer Prevention That Can Be Exploited by Combination with NSAIDs

Ezra E.W. Cohen, Sendi Rafael Adame-Garcia, Thomas S. Hoang, Kuniaki Sato, Paola Y. Anguiano Quiroz, Pham Thuy Tien Vo, Sydney I. Ramirez, Amaya N. Mendez-Molina, J. Silvio Gutkind, Farhoud Faraji, Alfredo Molinolo, Tomohiko Ishikawa, Scott M. Lippman, Xingyu Wu, Prashant Mali, Kai-Xi Fan, Tracy Guo
article en

Abstract

Our findings reveal that using metformin for head and neck cancer chemoprevention leads to compensatory activation of a PKA-driven resistance mechanism that can be blocked by cotreatment with NSAIDs. These findings provide a rationale for combining metformin with NSAIDs as a precision head and neck cancer chemoprevention strategy.

Cancer Prevention ResearchVol. 19(2)
La Jolla Institute for Immunology (US), University of San Diego (US), National Foundation for Cancer Research (US), UC San Diego Health System (US), University of California System (US), University of California San Diego (US), La Jolla Bioengineering Institute (US), La Jolla Institute For Molecular Medicine (US)
Openalex Percentile: Top 63%
Metabolism, Diabetes, and Cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.